Comparison of intrathecal chemotherapy for leptomeningeal carcinomatosis of a solid tumor: methotrexate alone versus methotrexate in combination with cytosine arabinoside and hydrocortisone. 2003

Dae-Young Kim, and Keun-Wook Lee, and Tak Yun, and Sook Ryun Park, and Joo Young Jung, and Dong-Wan Kim, and Tae-You Kim, and Dae Seog Heo, and Yung-Jue Bang, and Noe Kyeong Kim
Department of Internal Medicine, Seoul National University College of Medicine, Seoul, Korea.

OBJECTIVE To compare the efficacy of intrathecal methotrexate single therapy with three-drug combination therapy in patients with leptomeningeal carcinomatosis. METHODS Fifty-five patients who had pathologically proven leptomeningeal carcinomatosis of a solid tumor were evaluated in terms of pathological response. Group M (n = 29) received methotrexate 15 mg and group MHA (n = 26) received methotrexate 15 mg, hydrocortisone 15 mg/m(2) and ara-C 30 mg/m(2) twice a week intrathecally until a cytological response was obtained. RESULTS Primary sites of the tumor were the lung (n = 33), breast (n = 13) and stomach (n = 5). The pathology of 45 patients was adenocarcinoma. The cytological response rate to intrathecal chemotherapy was significantly higher in the MHA group than in the M group (38.5 vs 13.8%, P = 0.036). The median survival was 18.6 weeks in the MHA arm and 10.4 weeks in the M arm (P = 0.029). CONCLUSIONS Combination intrathecal chemotherapy with methotrexate, cytosine arabinoside and hydrocortisone showed more favorable effects than methotrexate single therapy for leptomeningeal carcinomatosis in solid tumors.

UI MeSH Term Description Entries
D007278 Injections, Spinal Introduction of therapeutic agents into the spinal region using a needle and syringe. Injections, Intraspinal,Injections, Intrathecal,Intraspinal Injections,Intrathecal Injections,Spinal Injections,Injection, Intraspinal,Injection, Intrathecal,Injection, Spinal,Intraspinal Injection,Intrathecal Injection,Spinal Injection
D008297 Male Males
D008577 Meningeal Neoplasms Benign and malignant neoplastic processes that arise from or secondarily involve the meningeal coverings of the brain and spinal cord. Intracranial Meningeal Neoplasms,Spinal Meningeal Neoplasms,Benign Meningeal Neoplasms,Leptomeningeal Neoplasms,Malignant Meningeal Neoplasms,Meningeal Cancer,Meningeal Neoplasms, Benign,Meningeal Neoplasms, Intracranial,Meningeal Neoplasms, Malignant,Meningeal Tumors,Neoplasms, Leptomeningeal,Neoplasms, Meningeal,Benign Meningeal Neoplasm,Cancer, Meningeal,Cancers, Meningeal,Intracranial Meningeal Neoplasm,Leptomeningeal Neoplasm,Malignant Meningeal Neoplasm,Meningeal Cancers,Meningeal Neoplasm,Meningeal Neoplasm, Benign,Meningeal Neoplasm, Intracranial,Meningeal Neoplasm, Malignant,Meningeal Neoplasm, Spinal,Meningeal Neoplasms, Spinal,Meningeal Tumor,Neoplasm, Benign Meningeal,Neoplasm, Intracranial Meningeal,Neoplasm, Leptomeningeal,Neoplasm, Malignant Meningeal,Neoplasm, Meningeal,Neoplasm, Spinal Meningeal,Neoplasms, Benign Meningeal,Neoplasms, Intracranial Meningeal,Neoplasms, Malignant Meningeal,Neoplasms, Spinal Meningeal,Spinal Meningeal Neoplasm,Tumor, Meningeal,Tumors, Meningeal
D008727 Methotrexate An antineoplastic antimetabolite with immunosuppressant properties. It is an inhibitor of TETRAHYDROFOLATE DEHYDROGENASE and prevents the formation of tetrahydrofolate, necessary for synthesis of thymidylate, an essential component of DNA. Amethopterin,Methotrexate Hydrate,Methotrexate Sodium,Methotrexate, (D)-Isomer,Methotrexate, (DL)-Isomer,Methotrexate, Dicesium Salt,Methotrexate, Disodium Salt,Methotrexate, Sodium Salt,Mexate,Dicesium Salt Methotrexate,Hydrate, Methotrexate,Sodium, Methotrexate
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D003561 Cytarabine A pyrimidine nucleoside analog that is used mainly in the treatment of leukemia, especially acute non-lymphoblastic leukemia. Cytarabine is an antimetabolite antineoplastic agent that inhibits the synthesis of DNA. Its actions are specific for the S phase of the cell cycle. It also has antiviral and immunosuppressant properties. (From Martindale, The Extra Pharmacopoeia, 30th ed, p472) Ara-C,Arabinofuranosylcytosine,Arabinosylcytosine,Cytosine Arabinoside,Aracytidine,Aracytine,Cytarabine Hydrochloride,Cytonal,Cytosar,Cytosar-U,beta-Ara C,Ara C,Arabinoside, Cytosine,Cytosar U,beta Ara C
D004334 Drug Administration Schedule Time schedule for administration of a drug in order to achieve optimum effectiveness and convenience. Administration Schedule, Drug,Administration Schedules, Drug,Drug Administration Schedules,Schedule, Drug Administration,Schedules, Drug Administration
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D006854 Hydrocortisone The main glucocorticoid secreted by the ADRENAL CORTEX. Its synthetic counterpart is used, either as an injection or topically, in the treatment of inflammation, allergy, collagen diseases, asthma, adrenocortical deficiency, shock, and some neoplastic conditions. Cortef,Cortisol,Pregn-4-ene-3,20-dione, 11,17,21-trihydroxy-, (11beta)-,11-Epicortisol,Cortifair,Cortril,Epicortisol,Hydrocortisone, (11 alpha)-Isomer,Hydrocortisone, (9 beta,10 alpha,11 alpha)-Isomer,11 Epicortisol

Related Publications

Dae-Young Kim, and Keun-Wook Lee, and Tak Yun, and Sook Ryun Park, and Joo Young Jung, and Dong-Wan Kim, and Tae-You Kim, and Dae Seog Heo, and Yung-Jue Bang, and Noe Kyeong Kim
September 2012, Orvosi hetilap,
Dae-Young Kim, and Keun-Wook Lee, and Tak Yun, and Sook Ryun Park, and Joo Young Jung, and Dong-Wan Kim, and Tae-You Kim, and Dae Seog Heo, and Yung-Jue Bang, and Noe Kyeong Kim
June 2003, Cancer,
Dae-Young Kim, and Keun-Wook Lee, and Tak Yun, and Sook Ryun Park, and Joo Young Jung, and Dong-Wan Kim, and Tae-You Kim, and Dae Seog Heo, and Yung-Jue Bang, and Noe Kyeong Kim
November 1982, Nihon Naika Gakkai zasshi. The Journal of the Japanese Society of Internal Medicine,
Dae-Young Kim, and Keun-Wook Lee, and Tak Yun, and Sook Ryun Park, and Joo Young Jung, and Dong-Wan Kim, and Tae-You Kim, and Dae Seog Heo, and Yung-Jue Bang, and Noe Kyeong Kim
March 1973, European journal of cancer,
Dae-Young Kim, and Keun-Wook Lee, and Tak Yun, and Sook Ryun Park, and Joo Young Jung, and Dong-Wan Kim, and Tae-You Kim, and Dae Seog Heo, and Yung-Jue Bang, and Noe Kyeong Kim
January 1990, Haematology and blood transfusion,
Dae-Young Kim, and Keun-Wook Lee, and Tak Yun, and Sook Ryun Park, and Joo Young Jung, and Dong-Wan Kim, and Tae-You Kim, and Dae Seog Heo, and Yung-Jue Bang, and Noe Kyeong Kim
March 1996, Surgical neurology,
Dae-Young Kim, and Keun-Wook Lee, and Tak Yun, and Sook Ryun Park, and Joo Young Jung, and Dong-Wan Kim, and Tae-You Kim, and Dae Seog Heo, and Yung-Jue Bang, and Noe Kyeong Kim
January 1975, Cancer chemotherapy reports,
Dae-Young Kim, and Keun-Wook Lee, and Tak Yun, and Sook Ryun Park, and Joo Young Jung, and Dong-Wan Kim, and Tae-You Kim, and Dae Seog Heo, and Yung-Jue Bang, and Noe Kyeong Kim
March 2021, Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology,
Dae-Young Kim, and Keun-Wook Lee, and Tak Yun, and Sook Ryun Park, and Joo Young Jung, and Dong-Wan Kim, and Tae-You Kim, and Dae Seog Heo, and Yung-Jue Bang, and Noe Kyeong Kim
January 2021, Indian journal of cancer,
Dae-Young Kim, and Keun-Wook Lee, and Tak Yun, and Sook Ryun Park, and Joo Young Jung, and Dong-Wan Kim, and Tae-You Kim, and Dae Seog Heo, and Yung-Jue Bang, and Noe Kyeong Kim
June 2022, World journal of clinical cases,
Copied contents to your clipboard!